# Statin and Bone Health

> **NCT05613400** · PHASE4 · UNKNOWN · sponsor: **The University of Hong Kong** · enrollment: 240 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Simvastatin 10mg
- **DRUG:** Ezetimibe 10mg

## Key facts

- **NCT ID:** NCT05613400
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-04-13
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-06-30
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2022-11-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05613400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05613400, "Statin and Bone Health". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05613400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*